A single dose of neoadjuvant PD-1 blockade predicts clinical outcomes in resectable melanoma.

Huang, Alexander C; Orlowski, Robert J; Xu, Xiaowei; Mick, Rosemarie; George, Sangeeth M; Yan, Patrick K; Manne, Sasikanth; Kraya, Adam A; Wubbenhorst, Bradley; Dorfman, Liza; D'Andrea, Kurt; Wenz, Brandon M; Liu, Shujing; Chilukuri, Lakshmi; Kozlov, Andrew; Carberry, Mary; Giles, Lydia; Kier, Melanie W; Quagliarello, Felix; McGettigan, Suzanne; Kreider, Kristin; Annamalai, Lakshmanan; Zhao, Qing; Mogg, Robin; Xu, Wei; Blumenschein, Wendy M; Yearley, Jennifer H; Linette, Gerald P; Amaravadi, Ravi K; Schuchter, Lynn M; Herati, Ramin S; Bengsch, Bertram; Nathanson, Katherine L; Farwell, Michael D; Karakousis, Giorgos C; Wherry, E John; Mitchell, Tara C.
Nat Med; 25(3): 454-461, 2019 03.
Artigo em Inglês | MEDLINE | ID: mdl-30804515